ScripsAmerica Comments on 10-Q for the Second Quarter of 2014
Marketwire - Mon Aug 18, 7:01AM CDT
ScripsAmerica Inc. (OTCBB: SCRC), today commented on the Company's recent 10-Q filing for the second quarter ended June 30, 2014.
Ironridge Global IV, Ltd. Successfully Obtains Final Enforcement Order Against ScripsAmerica, Inc.
ACCESSWIRE - Wed Aug 13, 3:31PM CDT
Los Angeles, CA / ACCESSWIRE / August 13, 2014 / Ironridge Global IV, Ltd. has obtained a final order against ScripsAmerica, Inc. (OTCBB: SCRC), fully upholding the original stipulated settlement agreement of the parties.
ScripsAmerica's Specialty Pharmacy Receives Approved Orders of $4.1 Million in July Marking Its Fourth Consecutive Month of Sales Growth
Marketwire - Mon Aug 04, 7:00AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company's managed specialty pharmacy reported $4,090,000 in approved orders during the month of July 2014.
ScripsAmerica's Managed Specialty Pharmacy on Pace for Record Month
Marketwire - Mon Jul 21, 7:01AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company's managed specialty pharmacy reported $1.5 million in approved prescription orders during the first half of July.
Wholesale Rx, ScripsAmerica's Equity Venture, Reports Significant YoY Revenue Growth During Q2 2014
Marketwire - Mon Jul 14, 7:30AM CDT
ScripsAmerica Inc. (OTCBB: SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company's equity venture, Wholesale Rx "WRx," received and processed $696,808 in orders during the quarter ended June 30, 2014 compared to $26,000 during the same quarter in 2013, prior to ScripsAmerica's involvement with the company.
ScripsAmerica's Equity Venture, Wholesale Rx, Reports 93% Revenue Growth During the First Quarter of 2014
Marketwire - Wed Jul 09, 7:30AM CDT
ScripsAmerica Inc. (OTCBB: SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company's equity venture, Wholesale Rx "WRx," reported quarterly revenue growth of 93% from Q4 2013 to Q1 2014.
ScripsAmerica's Managed Specialty Pharmacy Receives Approved Orders of $2.7 Million in June
Marketwire - Mon Jul 07, 7:30AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company's managed specialty pharmacy reported $2,706,709 in prescription approved orders during the month of June.
ScripsAmerica Completes Prepayment of Outstanding Convertible Debt
Marketwire - Mon Jun 23, 8:15AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company has completed the prepayment of its outstanding convertible debt.
ScripsAmerica Issues Second Payment on Largest Convertible Note
GlobeNewswire - Wed Apr 02, 8:43AM CDT
ScripsAmerica Inc. (OTCBB:SCRC), today announced that the Company has issued the second payment due on its convertible note with the largest principal and closest conversion date.
ScripsAmerica Reports March Revenue of Over $494,000 for Its Managed Specialty Pharmacy
GlobeNewswire - Tue Apr 01, 8:25AM CDT
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the specialty pharmacy it recently entered into a management agreement with recorded $494,643 in prescription sales for the month of March.
ScripsAmerica Prepays $50,000 Convertible Promissory Note
GlobeNewswire - Mon Mar 31, 7:30AM CDT
ScripsAmerica Inc. (OTCBB:SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced the prepayment of an outstanding convertible note in the principal amount of $50,000.
ScripsAmerica's Pharmaceutical Equity Venture, Wholesale Rx, Continues Revenue Growth in February
GlobeNewswire - Mon Mar 24, 7:33AM CDT
ScripsAmerica Inc. (OTCBB:SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company's equity venture, Wholesale Rx "WRx," received and processed $313,904 in orders during the month of February.
ScripsAmerica Prepays Another Convertible Promissory Note
GlobeNewswire - Mon Mar 17, 7:30AM CDT
ScripsAmerica Inc. (OTCBB:SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company has prepaid the entire balance of an outstanding convertible promissory note with a principal amount of $50,000.
ScripsAmerica Announces Prepayment of Convertible Promissory Note
GlobeNewswire - Wed Mar 12, 7:46AM CDT
ScripsAmerica Inc. (OTCBB:SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company has prepaid the balance of an outstanding convertible promissory note with a principal amount of $40,000.
ScripsAmerica Secures $200,000 RapiMed Purchase Order for Hong Kong Market
GlobeNewswire - Mon Mar 10, 9:02AM CDT
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has secured a $200,000 purchase order for RapiMed(R) from Global Pharma Hub for the Hong Kong market.
ScripsAmerica Enters Licensing Agreement to Market and Distribute RapiMed in Canada
GlobeNewswire - Wed Mar 05, 7:30AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has entered into a sublicensing agreement for the marketing and distribution of RapiMed(R) in Canada. ScripsAmerica will now have access to the growing Canadian OTC drug market, which was valued at over $3.1 Billion in 2012.
ScripsAmerica Signs Business Management Agreement With a New Jersey Compounding Pharmacy
GlobeNewswire - Thu Feb 20, 7:30AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has entered into a business management agreement with a New Jersey compounding pharmacy.
ScripsAmerica Commences Prepayment of Convertible Notes
GlobeNewswire - Wed Feb 19, 7:30AM CST
ScripsAmerica Inc. (OTCBB:SCRC), today announced that the Company has commenced the prepayment of its outstanding convertible debt by issuing the first payment on its convertible note with the largest principal and closest conversion date.
ScripsAmerica's Pharmaceutical Equity Venture Generates Record Revenue for Second Consecutive Month
GlobeNewswire - Wed Feb 12, 7:30AM CST
ScripsAmerica Inc. (OTCBB:SCRC), today announced that during the month of January, the Company's equity venture, Wholesale Rx "WRx," received and processed $268,696 in orders, setting a second consecutive monthly revenue record.
ScripsAmerica's RapiMed Product Receives Registration Approval From the Hong Kong Government
GlobeNewswire - Mon Feb 10, 7:30AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has received registration approval for its RapiMed(R) Children's Pain Reliever & Fever Reducer from the Government of Hong Kong.